07:02 AM EDT, 04/30/2026 (MT Newswires) -- Eli Lilly (LLY) reported Q1 non-GAAP earnings Thursday of $8.55 per diluted share, up from $3.34 a year earlier.

Analysts polled by FactSet expected $6.97.

Revenue for the quarter ended March 31 was $19.80 billion, up from $12.73 billion a year earlier.

Analysts surveyed by FactSet expected $17.82 billion.

For 2026, the drug major raised its adjusted EPS guidance to between $35.50 and $37.00 from $33.50 to $35.00 and its revenue guidance to between $82 billion and $85 billion from $80 billion to $83 billion.

Analysts polled by FactSet expect $34.51 and $82.07 billion, respectively.

Shares of the company were up 6% in recent premarket activity.